-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NxsvIh1aYsNf3Zmx2GBSOd30jwf7P1ogULtkN/spnCZLCgHuFB91qOhP2IWrZAcp 2aC97lpswLgM7E+xK3jcDA== 0001230295-05-000150.txt : 20050705 0001230295-05-000150.hdr.sgml : 20050704 20050705143408 ACCESSION NUMBER: 0001230295-05-000150 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050630 FILED AS OF DATE: 20050705 DATE AS OF CHANGE: 20050705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEISSBACH HERBERT CENTRAL INDEX KEY: 0001218823 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 05936225 MAIL ADDRESS: STREET 1: 8008 DESMOND DR CITY: BOYNTON BEACH STATE: FL ZIP: 33437 4 1 wei17.xml X0202 4 2005-06-30 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001218823 WEISSBACH HERBERT 8008 DESMOND DR. BOYNTON BEACH FL 33437 1 0 0 0 Common Stock, $.01 par value per share 2005-06-30 4 A 0 850 4.4100 A 21417 D Option to Purchase Common Stock, $.01 par value 4.4100 2005-06-30 4 A 0 5000 4.4100 A 2006-06-30 2015-06-30 Common Stock, $.01 par value per share 5000 5000 D These shares were granted pursuant to the Company's 2004 Incentive Plan, which provides for the grant to non-employee directors of that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter equal to $3,750.00, until he is no longer an Outside Director. On June 30, 2005, the fair market value of the Common Stock, based on the closing price, was $4.41. These options will become fully vested and immediately exercisable on 06/30/2006. By: Beata A. Smith as Attorney-In-Fact for 2005-07-01 -----END PRIVACY-ENHANCED MESSAGE-----